MRDDF News Alert Miranda Gold Corp (MRDDF) 0.0831 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Miranda Gold Corp (MRDDF) 0.0831 $MRDDF

Miranda Gold Modifies Terms of Share Purchase Warrants
Filing Services Canada XHTML - Wed Dec 17, 6:01AM CST

MAD.VN: 0.115 (+0.005)

Miranda Gold Signs Joint Venture Agreement to Advance High-Grade Willow Creek Project Towards Production
Filing Services Canada XHTML - Mon Nov 17, 11:44AM CST

MAD.VN: 0.115 (+0.005)

Miranda Gold Files Technical Report for the Willow Creek Project, Alaska
Filing Services Canada XHTML - Thu Oct 23, 5:08PM CDT

MAD.VN: 0.115 (+0.005)

Miranda Gold  Identifies New High-Grade Vein at Willow Creek, Alaska
Filing Services Canada XHTML - Wed Oct 15, 6:01AM CDT

MAD.VN: 0.115 (+0.005)

Miranda Gold Director Resigns
Business Wire - Fri Sep 12, 6:00AM CDT
Miranda Gold Corp. ("Miranda" (TSX-V: MAD) reports that Steve Ristorcelli, has resigned as a director of Miranda. He has served as a non-executive independent director for the past 19 years.
MAD.VN: 0.115 (+0.005)

Miranda Gold Completes 43-101 Resource Estimate for Upper Coleman Deposit on Willow Creek Project, Alaska
Filing Services Canada XHTML - Thu Sep 11, 6:04AM CDT

MAD.VN: 0.115 (+0.005)

Miranda Gold Director Retires and Options Granted
Filing Services Canada XHTML - Thu Sep 04, 4:04PM CDT

MAD.VN: 0.115 (+0.005)

Miranda Agrees to Joint Venture Terms to Develop Its Willow Creek Project, Alaska
Business Wire - Wed Aug 06, 6:00AM CDT
Miranda Gold Corp. ("Miranda" (TSX-V: MAD) is pleased to announce that it has signed a Letter of Intent ("LOI" with Gold Torrent, Inc. ("Gold Torrent" (GTOR:QBB) on its Willow Creek project in Alaska.
MAD.VN: 0.115 (+0.005)

Miranda and Prism Agreement Effective for Cerro Oro Project, Colombia
Business Wire - Mon Jun 23, 7:06PM CDT
Miranda Gold Corp. ("Miranda" (TSX-V: MAD) and Prism Resources Inc. ("Prism" (NEX RS.H) are pleased to announce that further to the press release dated April 2, 2014, the agreement with Prism is now effective and Prism issued Miranda 200,000 common shares, and reimbursed Miranda US$90,000 that were paid by Miranda to the underlying leaseholder. Prism will be obligated to fund exploration related expenditures of US$4,000,000 to earn a 51% interest and through additional funding can earn an additional 19% for a total interest of 70%.
MAD.VN: 0.115 (+0.005)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading